These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 28099066)

  • 1. New Vaccines against Epidemic Infectious Diseases.
    Røttingen JA; Gouglas D; Feinberg M; Plotkin S; Raghavan KV; Witty A; Draghia-Akli R; Stoffels P; Piot P
    N Engl J Med; 2017 Feb; 376(7):610-613. PubMed ID: 28099066
    [No Abstract]   [Full Text] [Related]  

  • 2. The 20th century re-emergence of epidemic infectious diseases: lessons learned and future prospects.
    Gubler DJ
    Med J Aust; 2012 Mar; 196(5):293-4. PubMed ID: 22432653
    [No Abstract]   [Full Text] [Related]  

  • 3. Risk communication – A moving target in the fight against infectious hazards and epidemics.
    Wkly Epidemiol Rec; 2016 Feb; 91(7):82-7. PubMed ID: 26897761
    [No Abstract]   [Full Text] [Related]  

  • 4. Funding vaccines for emerging infectious diseases.
    Wong G; Qiu X
    Hum Vaccin Immunother; 2018 Jul; 14(7):1760-1762. PubMed ID: 29194012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SELECTED EPIDEMICS & EMERGING PATHOGENS - PREVENTIVE STRATEGIES.
    Dis Mon; 2017 Sep; 63(9):272-274. PubMed ID: 29737285
    [No Abstract]   [Full Text] [Related]  

  • 6. From hidden outbreaks to epidemic emergencies: the threat associated with neglecting emerging pathogens.
    Tetro JA
    Microbes Infect; 2019; 21(1):4-9. PubMed ID: 29959095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SELECTED EPIDEMICS & EMERGING PATHOGENS - CONCLUSION.
    Dis Mon; 2017 Sep; 63(9):277-278. PubMed ID: 29737287
    [No Abstract]   [Full Text] [Related]  

  • 8. Safer countries through global health security.
    Frieden TR; Tappero JW; Dowell SF; Hien NT; Guillaume FD; Aceng JR
    Lancet; 2014 Mar; 383(9919):764-6. PubMed ID: 24529561
    [No Abstract]   [Full Text] [Related]  

  • 9. UK vaccines network: Mapping priority pathogens of epidemic potential and vaccine pipeline developments.
    Noad RJ; Simpson K; Fooks AR; Hewson R; Gilbert SC; Stevens MP; Hosie MJ; Prior J; Kinsey AM; Entrican G; Simpson A; Whitty CJM; Carroll MW
    Vaccine; 2019 Oct; 37(43):6241-6247. PubMed ID: 31522809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Not Available].
    Puyvallée AB; Storeng KT
    Tidsskr Nor Laegeforen; 2017 Jun; 137(12-13):908-910. PubMed ID: 28655226
    [No Abstract]   [Full Text] [Related]  

  • 11. Accelerated vaccine development against emerging infectious diseases.
    Leblanc PR; Yuan J; Brauns T; Gelfand JA; Poznansky MC
    Hum Vaccin Immunother; 2012 Jul; 8(7):1010-2. PubMed ID: 22777091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fail to prepare no more.
    Nat Microbiol; 2017 Feb; 2():17030. PubMed ID: 28225003
    [No Abstract]   [Full Text] [Related]  

  • 13. Mapping time use in clinical trials for vaccines against emerging infectious diseases.
    Mandi H; Yimer SA; Norheim G
    Clin Trials; 2021 Jun; 18(3):286-294. PubMed ID: 33653146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cultivation of an Adaptive Domestic Network for Surveillance and Evaluation of Emerging Infections.
    Pinner RW; Lynfield R; Hadler JL; Schaffner W; Farley MM; Frank ME; Schuchat A
    Emerg Infect Dis; 2015 Sep; 21(9):1499-509. PubMed ID: 26289824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Self-disseminating vaccines for emerging infectious diseases.
    Murphy AA; Redwood AJ; Jarvis MA
    Expert Rev Vaccines; 2016; 15(1):31-9. PubMed ID: 26524478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Special issue: Emerging and re-emerging epidemics affecting global health. Editorial.
    Petersen B; Bakheit M; Ahmed J
    Transbound Emerg Dis; 2013 Nov; 60 Suppl 2():1. PubMed ID: 24589094
    [No Abstract]   [Full Text] [Related]  

  • 17. Vaccines for epidemic infections and the role of CEPI.
    Plotkin SA
    Hum Vaccin Immunother; 2017 Dec; 13(12):2755-2762. PubMed ID: 28375764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Publicly available software tools for decision-makers during an emergent epidemic-Systematic evaluation of utility and usability.
    Heslop DJ; Chughtai AA; Bui CM; MacIntyre CR
    Epidemics; 2017 Dec; 21():1-12. PubMed ID: 28576351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Infections at risk for epidemic or biological threat. Importance of the initial management of suspect patients].
    Leport C; Vittecoq D; Perronne C; Debord T; Carli P; Camphin P; Bricaire F;
    Presse Med; 2011 Apr; 40(4 Pt 1):336-40. PubMed ID: 21256694
    [No Abstract]   [Full Text] [Related]  

  • 20. 5. Infectious disease surveillance designated by the Infectious Disease Control Law, and the situation of emerging/re-emerging infectious diseases in Japan.
    Okabe N
    Intern Med; 2002 Jan; 41(1):61-2. PubMed ID: 11838598
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.